Irving Investors
Crossover fundNew York · Seed–Late Stage
Find your way into Irving Investors
Investment thesis
Irving Investors started as a dedicated equity fund targeting disruptive technology and high-growth opportunities and has broadened its scope into credit and private investments. The firm seeks to build meaningful relationships with companies, providing capital, expertise, and connections to drive growth and returns. It has participated in several successful private exits and also acts as a trusted advisor and limited partner in venture capital funds.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 5 of 5 portfolio companiesBiotech ×5Deep Tech ×3Medical Devices ×2AI & Machine Learning ×1Digital Health ×1Hardware ×1Healthtech ×1
HQs:United States×3
Investments · 5 tracked
founders shown can be your intro pathBy year:2022 · 12021 · 32020 · 15 dated
A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.
BiotechHealthtech
Co-investorsHighlight CapitalAmgen VenturesBlackRockBlackstone Life SciencesClarus VenturesFrazier Healthcare Partners+4 more
LUMICKS develops life science research tools that measure and apply forces around biological interactions to link structural and 'omics analysis to functional outcomes at the molecular and cellular level.
BiotechDeep TechHardwareMedical Devices
Andrea(Co-founder & Chief Scientific Officer)Gerrit(Co-founder & Director of Product Management and Marketing)Hugo(CEO)Edmee(Chief Financial Officer)Hannah(HR Director)
Co-investorsLauxera Capital PartnersSoftBank Vision FundEuropean Investment BankGilde HealthcarePura Vida InvestmentsT. Rowe Price
Metagenomi Therapeutics is an in vivo genome editing company that uses genetic material sourced from natural environments (metagenomics) to develop a toolbox of editing tools for deletion, integration, and correction of genetic mutations.
BiotechDeep TechMedical DevicesBerkeley, US
Brian Thomas(Executive Officer, Director, Promoter)in
BoardAndrew Farquharson(Director)Jak Knowles(Director)
Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent CapitalFrazier Life SciencesHumboldt+5 more
Model Medicines is an AI-powered biotechnology company that uses computation to discover and engineer small molecule drugs targeting disease-driving biological mechanisms.
AI & Machine LearningBiotechDeep TechDigital HealthLa Jolla, US
Daniel Haders(Executive Officer, Director)inDaniel Haders II, Ph.D(Founder, CEO)inSean Russell(Founder, Chief Operating Officer)inKip Quackenbush(Executive Officer, Director)inMarlon Evans(Executive Officer, Director)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Portfolio news
latest coverage across their companiesMetagenomi · za.investing.com · Aug 11, 2026
Model Medicines · fiercebiotech.com · May 15, 2026
Imago · imagosystems.com · Sep 4, 2025
Frequently asked questions
- How many investments has Irving Investors made?
- Irving Investors has 5 tracked investments.
- What stage does Irving Investors invest at?
- Irving Investors invests at the Seed, Late Stage stages.
- What sectors does Irving Investors focus on?
- Irving Investors focuses on Deep Tech, Sector Agnostic.
- Where is Irving Investors located?
- Irving Investors is headquartered in New York, US.
Images
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Battery Ventures is a global investment firm that has backed more than 450 companies over its 40-year history, operating its investment staff as a single global unit.
Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.